Abstract
Gastrointestinal tumor (GIST) is the most frequent mesenchymal malignancy of the gastrointestinal tract. Liver and peritoneum are the most frequent metastatic sites. Surgery is the standard treatment in patients with localized disease and imatinib mesylate has been shown to be an effective treatment in metastatic or unresectable disease. We present a case of ileal GIST that was diagnosed as metastatic just with the findings of the fluorodeoxyglucose positron emission tomography (PET) and showed a total response with Imatinib on PET.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
